level-one heading

プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Sanjay K.に依頼

United States

プロフィール概要

I am a life scientist with 19 years of post-Ph.D. experience in research on cancer signalling finding novel functions of oncogene and tumor suppressor genes. I am on the editorial board or serve as a reviewer on more than a dozen high impact scientific journals such as American Journal of Pathology, Proceedings of National Academy of Sciences USA (PNAS), PLoS One, Molecular Cancer Therapeutics, Cancer Research, Clinical Cancer Res, Cancer Prevention Research, Journal of Cancer Therapy, Open Journal of Pathology, Journal of Biosciences & Medicine, BioMed Central, Journal of Cancer Research, International Journal of Oncology Research, Journal of Pathology Research, International Journal of Zoology Research, Biochem & Biotech Research, Indian Journal Medical Research, Current Science, ICFAI Journal Biotechnology, International Science Journal etc. I also serve as expert on Webmedcentral.com and Editage.com. As a Scientific Review Advisor in General Dynamics serving Department of Defense- Congressionally Directed Medical Research Programs (DoD-CDMRP) I manage entire peer review process for various DoD-CDMRP Programs such as Gulf War Illness Research Program (GWIRP), Neurofibromatosis Research Program (NFRP), Amyotrophic Lateral Sclerosis Research Program (ALSRP), Autism Research Program (ARP), Multiple Sclerosis Research Program (MSRP), Tuberous Sclerosis Complex Research Program (TSCRP), Bone Marrow Failure Research Program (BMRF), Defense Medical Research and Development Program, Team Performance Training (JPC-1) Intra-, extramural (TPTI), En Route Care Award (JPC-6) (ERCR), Joint En Route Care Award (JPC-1) Intra-, extramural (JERC), Medical Simulation & Information Science Research Program (MSIS) (BAAs), Clinical and Rehabilitative Medicine Research Program (CRMRP) (BAAs), US Army Medical Research and Materiel Command Broad Agency Announcement for Extramural Res (BAA), Intramural Research & Development Programs (IRDP). 1. I manage all the processes in peer review of 6x DoD-Congressionally Directed Medical Research Programs. This includes managing initial scientific and administrative review of grant applications, program project grants, and training grant applications as well as research project applications submitted in response to Program Announcements and Broad Agency Announcements. 2. I simultaneously supervise ~20 direct and ~50 indirect personnel. These personnel include Scientific Review Officers (equivalent to Health Science Administrators), Scientific Quality Assurance Readers, Project Managers, Project Task Leads, Project Support Specialists, Review Technical Assistants, Editors, Editorial Quality Control Agents, and other support staff that assist in various processes and process chains. 3. For all programs, I am responsible for controlling their scope, overseeing the initiation and planning of program activities, coordinating the functional requirements of the peer-review in each program by generating the review specification sheets based on mechanisms that are offered in a fiscal year. 4. I draft and review the Program Announcements in tandem with CDMRP Program Manager for multiple CDMRP programs by providing scientific evaluation criteria for mechanisms while adhering to relevant federal guidelines. 5. I conduct employee and reviewer orientations, quality control, and risk management in accordance with CDMRP requirements. 6. I manage workload and project priorities and ensure timelines are adhered to. I direct staff to remain focused on project goals. 7. I plan and conduct application referral of over 500+ scientific proposals in multiple receipt cycles. I write specific guidelines for electronic grant proposal referral that I provide to supporting scientific review officers for managing various expert panels. 8. I supervise multiple peer review meetings simultaneously, orientation sessions, training activities, as well as oversee the smooth running of multiple simultaneous panels by providing the guidance on all demanding administrative matters. 9. I help in preparing and administering the annual budget for the peer-review of CDMRP programs and supervise the production of 600+ Summary Statements (SS) resulting from these reviews while ensuring that the production and editorial staff have adhere to stated budgets and timelines. 10. For financial reporting and tracking of the project deliverables, I perform routine project management while closely working with the integrated program team consisting of representatives from various contractors to ensure open and regular communication. 11. I update protocols, SOPs, SRO and Reviewer Handbooks, policy documents, training materials for various scientific and non-scientific staff to facilitate smooth operation of various tasks and to help in inculcating new business concepts, best business practices, and business solutions. I clarify administrative and policy requirements associated with peer review. 12. I help in drafting and enforcing scientific peer-review management policies and procedures, counseling Scientific Review Officers, performance evaluations of staff I supervise and recommend promotions. 13. I establish peer-review panels and refer applications to these panels. I supervise SROs to assemble expertise based balanced group of experts and consultants to serve on various peer-review panels. 14. I establish criteria and standards for review panels to follow based upon the requirement conveyed by the Programmatic Review Committees. 15. I contribute to review and drafting of Summary Statements making sure that all reviewer critiques, comments and discussion notes are captured and properly presented in summary statements 16. I review and advise on commercial competitive proposal against government RFP. 17. I respond to impromptu questions by peer-reviewers about peer-review criteria, applicant eligibility, period of performance, inclusion and exclusion of various focus and subjects area, requirement of preliminary data, need for personnel effort etc. 18. I regularly identify new capabilities to grow business and leverage existing client relationships. 19. I maintain personnel interactions and expectations, by planning, organizing, completing, and presenting assessments of program/project management concepts, analyses, studies, and procedures. I evaluate impacts and risks for existing and proposed projects, programs, processes, and policies/laws and implements improvements in internal teams meetings. 20. I attend to staffing needs by participating in interviews, mentoring new recruits, and conflict resolution. Additionally, I am also responsible for the training activities of all scientific personnel and for the weekly meetings with supporting Scientific Review Officers various programs. 21. I create and promote cohesive, tandem work environment in team settings. I discuss and develop strategies for personnel workload management 22. Utilize scientific knowledge and expertise to perform a variety of management functions associated with the scientific peer review and support personnel training and other contract activities. 23. I perform quality check on scientific and consumers reviewers’ online databases. I approve and sign all the deliverable documents, reports, and summary statement in all the programs I am managing. I would with SROs to identify and coordinate the participation of reviewers for each application. 24. I guide SROs in identifying and selecting reviewers by matching the expertise of the reviewer with the specific science contained in the research grant applications. Assist them in assessing each reviewer COIs. 25. I have served as a Scientific Review Officer on various DoD Broad Agency Announcement applications submitted to various military programs. I have conducted panel recruitment, expertise identification and COI searches/assessment, supervised and facilitated online, onsite application discussions among scientific and specialist reviewers, and written Summary Statements. 26. I serve as liaison between federal staff and Scientific Review Officers and reviewers. I ensure that high quality written reviews are obtained by SROs from the reviewers. I provided feedback and recommendation to Scientific Review Officers during the entire program cycle for panel management, critique monitoring and summary statement writing. 27. I organize in- person, online and teleconference peer-review meetings where grant applications submitted to various CDMRP programs that I am managing are discussed. 28. I establish peer-review panels and refer applications to these panels. I supervise SROs to assemble expertise based balanced group of experts and consultants to serve on various peer-review panels. 29. I establish criteria and standards for review panels to follow based upon the requirement conveyed by the Programmatic Review Committees. 30. I contribute to review and drafting of Summary Statements making sure that all reviewer critiques, comments and discussion notes are captured and properly presented in summary statements 31. I review and advise on commercial competitive proposal against government RFP.

専門分野

• ☆ Molecular Biology
• ☆ Counseling & Mental Health Support
• ☆ Sclerosis & Demyelinating Diseases
• ☆ Peer Review
• ☆ Scientific Proofreading & Editing
• ☆ Grant Writing
• ☆ Risk Management

サービス

• Research
• Consulting
• Product Development

職務経験

Scientific Review Manager

General Dynamics Information Technology

6月 2014 - 現在

Associate Professor

University of Delhi

1月 2010 - 6月 2014

Assistant Professor

Jefferson Medical College (Kimmel Cancer Center)

5月 2008 - 1月 2010

Assistant Professor

Thomas Jefferson University (Kimmel Cancer Center)

5月 2007 - 1月 2010

Research Instructor Faculty

Thomas Jefferson University (Kimmel Cancer Center)

12月 2005 - 4月 2007

Postdoctoral Fellow

Georgetown University (Lombardi Comprehensive Cancer Center)

9月 2002 - 11月 2005

Postdoctoral Research Associate

Albert Einstein College of Medicine (Chanin Cancer Center)

10月 2001 - 9月 2002

Postdoctoral Fellow

University of Tennessee Health Science Center

10月 1999 - 10月 2001

学歴

Ph.D. Genetics

University of Delhi

3月 1994 - 7月 2000

PhD (Genetics)

University of Delhi

3月 1994 - 7月 2000

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Pavlides, Stephanos and Gutierrez-Pajares, Jorge L and Katiyar, Sanjay and Jasmin, Jean-Fran{\c{c}}ois and Mercier, Isabelle and Walters, Rhonda and Pavlides, Christos and Pestell, Richard G and Lisanti, Michael P and Frank, Philippe G(2014). Caveolin-1 regulates the anti-atherogenic properties of macrophages. Cell and tissue research. 358. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 821--831. Springer Berlin Heidelberg

Ju, Xiaoming and Casimiro, Mathew C and Gormley, Michael and Meng, Hui and Jiao, Xuanmao and Katiyar, Sanjay and Crosariol, Marco and Chen, Ke and Wang, Min and Quong, Andrew A and others(2014). Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial--mesenchymal restraint. Cancer research. 74. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 508--519. American Association for Cancer Research

Trimmer, Casey and Bonuccelli, Gloria and Katiyar, Sanjay and Sotgia, Federica and Pestell, Richard G and Lisanti, Michael P and Capozza, Franco(2013). Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activation. The American journal of pathology. 182. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 992--1004. Elsevier

Capozza, Franco and Trimmer, Casey and Castello-Cros, Remedios and Katiyar, Sanjay and Whitaker-Menezes, Diana and Follenzi, Antonia and Crosariol, Marco and Llaverias, Gemma and Sotgia, Federica and Pestell, Richard G and others(2012). Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration. Cancer research. 72. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2262--2274. AACR

Katiyar, Sanjay and Balani, Sneha and Singh, Virendra(2012). Novel lymphoblastoid cell lines from primary neoplasms of the upper aero-digestive tract. The Indian journal of medical research. 135. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 803. Medknow Publications

Katiyar, Sanjay and Jiao, Xuanmao and Addya, Sankar and Ertel, Adam and Covarrubias, Yolanda and Rose, Vanessa and Casimiro, Mathew C and Zhou, Jie and Lisanti, Michael P and Nasim, Talat and others(2012). Mammary gland selective excision of c-jun identifies its role in mRNA splicing. Cancer research. 72. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1023--1034. AACR

Wu, Kongming and Jiao, Xuanmao and Li, Zhaoming and Katiyar, Sanjay and Casimiro, Mathew C and Yang, Wancai and Zhang, Qiong and Willmarth, Nicole E and Chepelev, Iouri and Crosariol, Marco and others(2011). Cell fate determination factor Dachshund reprograms breast cancer stem cell function. Journal of Biological Chemistry. 286. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2132--2142. American Society for Biochemistry and Molecular Biology

Khurana, Sachin and Katiyar, Sanjay(2011). Cancer stem cells.

Janowski, Einsley and Jiao, Xuanmao and Katiyar, Sanjay and Lisanti, Michael P and Liu, Manran and Pestell, Richard G and Morad, Martin(2011). c-Jun is required for TGF-$β$-mediated cellular migration via nuclear Ca2+ signaling. The international journal of biochemistry & cell biology. 43. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1104--1113. Pergamon

Yu, Zuoren and Willmarth, Nicole E and Zhou, Jie and Katiyar, Sanjay and Wang, Min and Liu, Yang and McCue, Peter A and Quong, Andrew A and Lisanti, Michael P and Pestell, Richard G(2010). microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proceedings of the National Academy of Sciences. 107. (18). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 8231--8236. National Acad Sciences

Katiyar, Sanjay and Casimiro, Mathew C and Dettin, Luis and Ju, Xiaoming and Wagner, Erwin F and Tanaka, Hirokazu and Pestell, Richard G(2010). C-jun inhibits mammary apoptosis in vivo. Molecular biology of the cell. 21. (23). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 4264--4274. Am Soc Cell Biol

Jiao, Xuanmao and Katiyar, Sanjay and Willmarth, Nicole E and Liu, Manran and Ma, Xiaojing and Flomenberg, Neal and Lisanti, Michael P and Pestell, Richard G(2010). c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. Journal of Biological Chemistry. 285. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 8218--8226. American Society for Biochemistry and Molecular Biology

Liu, Manran and Sakamaki, Toshiyuki and Casimiro, Mathew C and Willmarth, Nicole E and Quong, Andrew A and Ju, Xiaoming and Ojeifo, John and Jiao, Xuanmao and Yeow, Wen-Shuz and Katiyar, Sanjay and others(2010). The canonical NF-$κ$B pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer research. 70. (24). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 10464--10473. AACR

Bonuccelli, Gloria and Casimiro, Mathew C and Sotgia, Federica and Wang, Chenguang and Liu, Manran and Katiyar, Sanjay and Zhou, Jie and Dew, Elliott and Capozza, Franco and Daumer, Kristin M and others(2009). Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. The American journal of pathology. 174. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1650--1662. Elsevier

Sotgia, Federica and Del Galdo, Francesco and Casimiro, Mathew C and Bonuccelli, Gloria and Mercier, Isabelle and Whitaker-Menezes, Diana and Daumer, Kristin M and Zhou, Jie and Wang, Chenguang and Katiyar, Sanjay and others(2009). Caveolin-1-/- Null Mammary Stromal Fibroblasts Share Characteristics with Human Breast Cancer-Associated Fibroblasts. The American journal of pathology. 174. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 746--761. Elsevier

Liu, Manran and Ju, Xiaoming and Willmarth, Nicole E and Casimiro, Mathew C and Ojeifo, John and Sakamaki, Toshiyuki and Katiyar, Sanjay and Jiao, Xuanmao and Popov, Vladimir M and Yu, Zuoren and others(2009). Nuclear factor-$κ$B enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. The American journal of pathology. 174. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1910--1920. Elsevier

Wu, Kongming and Katiyar, Sanjay and Witkiewicz, Agnes and Li, Anping and McCue, Peter and Song, Liang-Nian and Tian, Lifeng and Jin, Ming and Pestell, Richard G(2009). The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer research. 69. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3347--3355. AACR

Liu, Manran and Casimiro, Mathew C and Wang, Chenguang and Shirley, L Andrew and Jiao, Xuanmao and Katiyar, Sanjay and Ju, Xiaoming and Li, Zhiping and Yu, Zuoren and Zhou, Jie and others(2009). p21CIP1 attenuates Ras-and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proceedings of the National Academy of Sciences. 106. (45). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 19035--19039. National Acad Sciences

Li, Zhiping and Wang, Chenguang and Jiao, Xuanmao and Katiyar, Sanjay and Casimiro, Mathew C and Prendergast, George C and Powell, Michael J and Pestell, Richard G(2008). Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration. Journal of Biological Chemistry. 283. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 7007--7015. ASBMB

Jiao, Xuanmao and Katiyar, Sanjay and Liu, Manran and Mueller, Susette C and Lisanti, Michael P and Li, Anping and Pestell, Timothy G and Wu, Kongming and Ju, Xiaoming and Li, Zhiping and others(2008). Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase. Molecular biology of the cell. 19. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1378--1390. Am Soc Cell Biol

Lindsay, Jaime and Jiao, Xuanmao and Sakamaki, Toshiyuki and Casimiro, Mathew C and Shirley, Lawrence A and Tran, Thai H and Ju, Xiaoming and Liu, Manran and Li, Zhiping and Wang, Chenguang and others(2008). ErbB2 induces Notch1 activity and function in breast cancer cells. Clinical and translational science. 1. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 107--115. Wiley Online Library

Wu, Kongming and Katiyar, Sanjay and Li, Anping and Liu, Manran and Ju, Xiaoming and Popov, Vladimir M and Jiao, Xuanmao and Lisanti, Michael P and Casola, Antonella and Pestell, Richard G(2008). Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. Proceedings of the National Academy of Sciences. 105. (19). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 6924--6929. National Acad Sciences

Ju, Xiaoming and Katiyar, Sanjay and Wang, Chenguang and Liu, Manran and Jiao, Xuanmao and Li, Shengwen and Zhou, Jie and Turner, Jacob and Lisanti, Michael P and Russell, Robert G and others(2007). Akt1 governs breast cancer progression in vivo. Proceedings of the National Academy of Sciences. 104. (18). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 7438--7443. National Acad Sciences

Katiyar, Sanjay and Jiao, Xuanmao and Wagner, Erwin and Lisanti, Michael P and Pestell, Richard G(2007). Somatic excision demonstrates that c-Jun induces cellular migration and invasion through induction of stem cell factor. Molecular and cellular biology. 27. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1356--1369. Am Soc Microbiol

Sakamaki, Toshiyuki and Casimiro, Mathew C and Ju, Xiaoming and Quong, Andrew A and Katiyar, Sanjay and Liu, Manran and Jiao, Xuanmao and Li, Anping and Zhang, Xueping and Lu, Yinan and others(2006). Cyclin D1 determines mitochondrial function in vivo. Molecular and cellular biology. 26. (14). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 5449--5469. Am Soc Microbiol

Li, Zhiping and Jiao, Xuanmao and Wang, Chenguang and Ju, Xiaoming and Lu, Yinan and Yuan, Liangping and Lisanti, Michael P and Katiyar, Sanjay and Pestell, Richard G(2006). Cyclin D1 induction of cellular migration requires p27KIP1. Cancer research. 66. (20). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 9986--9994. AACR

Wang, Chenguang and Li, Zhiping and Lu, Yinan and Du, Runlei and Katiyar, Sanjay and Yang, Jianguo and Fu, Maofu and Leader, Jennifer E and Quong, Andrew and Novikoff, Phyllis M and others(2006). Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proceedings of the National Academy of Sciences. 103. (31). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 11567--11572. National Acad Sciences

Kumar, Arun and Katiyar, Sanjay Babu and Gupta, Suman and Chauhan, Prem MS(2006). Syntheses of new substituted triazino tetrahydroisoquinolines and $β$-carbolines as novel antileishmanial agents. European journal of medicinal chemistry. 41. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 106--113. Elsevier Masson

Hulit, James and Lee, Richard J and Li, Zhiping and Wang, Chenguang and Katiyar, Sanjay and Yang, Jianguo and Quong, Andrew A and Wu, Kongming and Albanese, Chris and Russell, Robert and others(2006). p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/$β$-catenin signaling. Cancer research. 66. (17). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 8529--8541. AACR

Katiyar, Sanjay and Hedau, Suresh and Jain, Neeraj and Kar, Premashish and Khuroo, Mohhamad S and Mohanta, J and Kumar, S and Gopalkrishna, Varanasi and Kumar, Nirmal and Das, Bhudev C(2005). p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer letters. 218. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 69--79. Elsevier

Katiyar, Sanjay and Thelma, BK and Murthy, NS and Hedau, Suresh and Jain, Neeraj and Gopalkrishna, V and Husain, Syed Akhtar and Das, Bhudev C(2003). Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Molecular and cellular biochemistry. 252. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 117--124. Springer Netherlands

Raghow, Sharan and Hooshdaran, Massoumeh Z and Katiyar, Sanjay and Steiner, Mitchell S(2002). Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Cancer research. 62. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1370--1376. AACR

Kailash, Uma and Hedau, S and Gopalkrishna, V and Katiyar, S and Das, BC(2002). A simple ‘paper smear’method for dry collection, transport and storage of cervical cytological specimens for rapid screening of HPV infection by PCR. Journal of medical microbiology. 51. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 606--683. Microbiology Society

A Ray, S L D Naik, S Katiyar, A Kumar, N S Murthy, S A Husain and B K Sharma*(2000). A comparative study on serum levels of testosterone and SHBG in carcinomas of breast and uterine cervix. Indian Journal of Biochemistry & Biophysics. 37. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 210--215.

Katiyar, Sanjay and Dash, Bipin C and Thakur, Varsha and Guptan, Raj C and Sarin, Shiv K and Das, Bhudev C(2000). P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Cancer. 88. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1565--1573. Wiley Online Library

Ray, A and Naik, SLD and Katiyar, S and Kumar, A and Murthy, NS and Sharma, S and Bahadur, AK and Pasha, ST and Husain, SA and Sharma, BK(2000). A comparative study on serum levels of testosterone and SHBG in carcinomas of breast and uterine cervix. NISCAIR-CSIR, India

Das, BC and Gopalkrishna, V and Hedau, Suresh and Katiyar, Sanjay(2000). Cancer of the uterine cervix and human papillomavirus infection. CURRENT SCIENCE-BANGALORE-. 78. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 52--63. CURRENT SCIENCE ASSOC/INDIAN ACADEMY OF SCIENCES

Jain, Anil and Kar, P and Gopalkrishna, V and Gangwal, P and others(1999). Hepatitis G virus (HGV) infection & its pathogenic significance in patients of cirrhosis. Indian Journal of Medical Research. 110. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 37. Indian Council of Medical Research

Jain, Anil and Kar, P and Goaplkrishna, V and Gangal, P and Katiyar, S and Das, BC(1999). The prevalence and pathogenic significance of hepatiti G-virus (HGV) in patients of cirrhosis in India. Indian Journal of Medical Research. 110. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 37--42. Indian Council of Medical Research

OTHER

Pestell, Richard G and Wu, Kongming and Jiao, Xuanmao and Katiyar, Sanjay and Popov, Vladimir M and Casimiro, Mathew(2011). Methods and compositions for the diagnosis, prognosis, and treatment of cancer.

Pestell, Richard G and Wu, Kongming and Jiao, Xuanmao and Katiyar, Sanjay and Popov, Vladimir M and Casimiro, Mathew(2011). Methods and compositions for the diagnosis, prognosis, and treatment of cancer.

Sakamaki, Toshiyuki and Liu, Manran and Katiyar, Sanjay and Rao, Mahadev and Li, Shiguang and Yin, Yuzhi and Dettin, Luis E and Pestell, Richard G and Glazer, Robert I(2005). ErbB2 activation of Notch1 signaling in breast cancer. American Association for Cancer Research

Das, Bhudev and Hedau, Suresh and Gopalkrishna, V and Katiyar, Sanjay and Kailash, U(2003). Cytological specimen loaded filter paper and an efficient method of using said paper for dry collection, transportation, and storage to screen for infection using PCR.

CONFERENCE PAPER

Shukla, Shirish and Hussain, Showket and Pande, Shailja and Varghese, P and Kaur, Harsimrut and Prusty, BK and others(2007). Mapping of human papillomavirus infections in cancers and pre-cancers of different organ sites in India. 24th International Papillomavirus Conference and Clinical Workshop. Beijing. 216.